Emmanuel Andres Ph.D
Department of Internal Medicine, University of Strasbourg, France · France
Editorial leadership for Journal of Hematology and Oncology Research ISSN 2372-6601
Research interests
- Immunity
- Host-Pathogens Relation
- Immune Cytopenias
- Systemic Immune
- Inflammatory Diseases
- Chronic Pathologies
- Telemedicine
- Drug-Induced Side Effects
- Vitamin Deficiency
Biography
In 1996, Dr Andres received his MD degree in Internal Medicine, at the University of Strasbourg, France. He worked as an associated professor in the University Hospital of Strasbourg, France. In 1998 he worked as PhD in Molecular Biology in the Laboratory of Professor Hoffmann (2011, Nobel Prize of Medicine) in the field of cationic antimicrobial peptides and pathogens - host relations. In 2002, he was nominated Professor at the University of Strasbourg, France. He also was in the head of an Internal Medicine Department (of 62 beads) in the University hospital of Strasbourg, France.
Selected publications
- Peripheral Blood Mononuclear Cells and Platelets Mitochondrial Dysfunction, Oxidative Stress, and Circulating mtDNA in Cardiovascular Diseases 2020 cited 56×
- Fat-Soluble Vitamins A, D, E, and K: Review of the Literature and Points of Interest for the Clinician 2024 cited 48×
- Two-Years Follow-Up of Symptoms and Return to Work in Complex Post-COVID-19 Patients 2023 cited 40×
- State of Art of Idiosyncratic Drug-Induced Neutropenia or Agranulocytosis, with a Focus on Biotherapies 2019 cited 39×
- Diagnosis, Treatment and Long-Term Management of Vitamin B12 Deficiency in Adults: A Delphi Expert Consensus 2024 cited 37×
- Skeletal and Respiratory Muscle Dysfunctions in Pulmonary Arterial Hypertension 2020 cited 37×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JHOR for your work?
This journal is guided by Emmanuel Andres (Department of Internal Medicine, University of Strasbourg, France) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.